SITC 2020 - Adaptimmune's SURPASS Poster

preview_player
Показать описание
Elliot Norry, M.D., Chief Medical Officer of Adaptimmune, discusses SURPASS data and plans moving forward
  1. Adaptimmune Therapeutics
  2. #SITC2020
Рекомендации по теме
SITC 2020 - 0:08:42

SITC 2020 - Adaptimmune's SURPASS Poster

Adaptimmune 0:13:09

Adaptimmune

Adaptimmune 0:13:16

Adaptimmune

Adaptimmune 0:14:35

Adaptimmune

Adaptimmune: SPEAR T-cells 0:06:02

Adaptimmune: SPEAR T-cells

Adaptimmune 0:15:06

Adaptimmune

Adaptimmune 0:15:36

Adaptimmune

E. Norry & 0:07:44

E. Norry & D. Williams present initial data from SPEARHEAD-1 trial

Jonathan Silk: Next 0:18:53

Jonathan Silk: Next Generation approaches to enhance the efficacy of SPEAR T-cells

$ADAP Adaptimmune Therapeutics 0:01:31

$ADAP Adaptimmune Therapeutics

Immunotherapy in common 0:02:40

Immunotherapy in common solid tumors: an overview

January 25 2022 1:09:37

January 25 2022 EASO OMTF Obesity Pharmacotherapy Update webinar recording